Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: A multivariate analysis of a multi- institutional experience

Cancer Journal from Scientific American

Volumn 3, Issue 1, 1997, Pages 52-56

  Corn, Benjamin W ^a,j   Donahue, Bernadine R ^b   Rosenstock, Jeffrey G ^c   Hyslop, Theresa ^a   Brandon, Alfred H ^d   Hegde, H H ^e   Cooper, Jay S ^b   Sherr, David L ^f   Fisher, Scot A ^g   Berson, Anthony ^e   Han, Hoke ^d   Abdel Wahab, May ^d   Koprowski, Christopher D ^h   Ruffer, James E ⁱ   Curran Jr , Walter J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e ST VINCENT S HOSPITAL   (United States)

^f NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^g GRADUATE HOSPITAL   (United States)

^h Department of Anesthesiology   (United States)

ⁱ HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^j THOMAS JEFFERSON UNIVERSITY   (United States)

more..

Author keywords

AIDS; lymphoma; primary central nervous system lymphoma; radiotherapy

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; BRAIN LYMPHOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CENTRAL NERVOUS SYSTEM NEOPLASMS; DEXAMETHASONE; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; RADIOTHERAPY; SURVIVAL ANALYSIS;

EID: 0030942020     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. CDC. Revision of the case definition of acquired immunodeficiency syndrome for national reporting - United States. MMWR 1985;34:373-375.
2. Levine AM. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst 1993;85:1382-1397.
3. Nelson DF, Martz KL, Bonner H et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1992;23: 9-17.
4. O'Neill BP, O'Fallon JR, Earle JD et al. Primary central nervous system non-Hodgkin's lymphoma: Survival advantages with combined modality initial therapy? Int J Radiat Oncol Biol Phys 1995; 33:663-673.
5. Neuwelt EA, Golman DL, Dahlborg SA et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991;9:1580-1590.
6. DeAngelis LM, Yahalom J, Thaler HT et al. Combined modality therapy for primary central nervous system lymphoma. J Clin Oncol 1992;10:635-643.
7. So YT, Beckstead JH, Davis RL. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 1986;20:566-572.
8. Formenti SC, Gill PS, Lean E. Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer 1989;63: 1101-1107.
9. Remick SC, Diamond CD, Migliozzi JA et al. Primary central nervous system lymphoma in patients with and without the Acquired Immune Deficiency Syndrome: a retrospective analysis and review of the literature. Medicine 1990;69:345-360.
10. Goldstein JD, Dickson DW, Moser FG et al. Primary central nervous system lymphoma in Acquired Immune Deficiency Syndrome: a clinical and pathologic study with results of treatment with radiation. Cancer 1991;67:2756-2765.
11. Fine H, Mayer R. Primary central nervous system lymphoma. Ann Int Med 1993;119:1093-1104.
12. Donahue BR, Sullivan JW, Cooper JS. Additional experience with empiric radiotherapy for presumed Human Immunodeficiency Virus-associated primary central nervous system lymphoma. Cancer 1995;76:328-332.
13. Carbone PP, Kaplan HS, Musshoff K. Report of the committee on Hodgkin's disease staging. Cancer Res 1971;31:1860-1861.
14. Fowler JF. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-694.
15. Glass J, Gruber ML, Cher L et al. Pre-irradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994;81:188-195.
16. Levine AM, Sullivan-Halley J, Pike MC. Human immunodeficiency virus-related lymphoma: prognostic factors predictive to survival. Cancer 1991;68:2466-2472.
17. Schultz CS, Scott C, Sherman W et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group protocol 88-06. J Clin Oncol 1996;14:556-564.
18. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system. J Neurosurg 1986;65:600-607.
19. Baumgartner JE, Rachlin JR, Beckstead JH et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73:206-211.
20. Corn BW, Trock BD, Curran WJ. Management of primary central nervous system lymphoma for the patient with the acquired immunodeficiency syndrome: confronting a clinical catch-22. Cancer 1995;76:163-166.
21. Galetto G, Levine A. AIDS associated primary central nervous system lymphoma (editorial). JAMA 1993;269:92-93.